Axil Brands, Inc. (AXIL) Stock Price & Analysis
Axil Brands, Inc. (AXIL) rose 5.26% to USD 6 as of July 26, 2026 at 09:42 UTC, according to Nexqual real-time market data.
AXIL last closed at USD 5.7; the session ranged USD 5.41–6 on volume of 7,157 shares. Market capitalization is $40.91M, with a 52-week range of USD 4.28–10.25 (ASE). Source: Nexqual, July 26, 2026 at 09:42 UTC.
Key Statistics (as of July 26, 2026 at 09:42 UTC)
| Price | USD 6 |
|---|---|
| Change | ▲ 5.26% (up) |
| Previous Close | USD 5.7 |
| Open | USD 5.82 |
| Day Range | USD 5.41 – 6 |
| 52-Week Range | USD 4.28 – 10.25 |
| Volume | 7,157 shares |
| Market Cap | $40.91M |
| Exchange | ASE |
Technical Analysis (AXIL)
Nexqual's technical model rates AXIL "SELL" based on 1 bullish and 4 bearish signals across 125 daily candles, as of July 26, 2026 at 09:42 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 46.47 (neutral) |
| vs SMA50 | Below (USD 6.4) |
| MACD | -0.18 (negative) |
Analyst Ratings (AXIL)
Wall Street analysts rate AXIL "None" based on 1 analysts, with a mean price target of USD 14.25 (range USD 14.25–14.25), per Nexqual as of July 26, 2026 at 09:42 UTC.
| Consensus Rating | None |
|---|---|
| Analyst Count | 1 |
| Mean Target | USD 14.25 |
| High Target | USD 14.25 |
| Low Target | USD 14.25 |
Earnings (AXIL)
| Revenue Estimate | $9.50M |
|---|
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-02-28 | USD 0.02 vs est 0.15 ▼ miss |
Source: Nexqual, July 26, 2026 at 09:42 UTC.
Financials & Fundamentals (AXIL)
| Total Revenue | $28.04M |
|---|---|
| Revenue Growth (YoY) | +5.40% |
| Gross Margin | +68.61% |
| Operating Margin | +2.94% |
| Profit Margin | +3.56% |
| ROE | +9.44% |
| Debt / Equity | 6.69 |
| Current Ratio | 3.67 |
| Total Cash | $5.52M |
| Total Debt | $766,232 |
| Free Cash Flow | $726,094 |
Source: Nexqual, July 26, 2026 at 09:42 UTC.
Financial Health Score (AXIL)
Nexqual rates Axil Brands, Inc.'s overall financial health "Mixed" across five dimensions, as of July 26, 2026 at 09:42 UTC.
| Growth | Solid — Revenue +5% YoY (latest Q) |
|---|---|
| Profitability | Weak — Pre-revenue or very early stage |
| Balance Sheet | Strong — $6M cash, no debt |
| Cash Flow | Solid — Operating cash flow $985K |
| Efficiency | Mixed — ROE 9%, ROA 7.0% |
Ownership (AXIL)
| Insider Ownership | +40.77% |
|---|---|
| Institutional Ownership | +21.11% |
| Shares Outstanding | 6.82M |
| Float | 3.47M |
| Short % of Float | +0.72% |
Source: Nexqual, July 26, 2026 at 09:42 UTC.
Leadership (AXIL)
Axil Brands, Inc. is led by Jeff Sasan Toghraie (age 57), CEO & Chairman, per Nexqual as of July 26, 2026 at 09:42 UTC.
| CEO & Chairman | Jeff Sasan Toghraie (age 57) |
|---|---|
| CFO, COO, Principal Accounting Officer & Director | Jeff Brown (age 43) |
| Director of Investor Relations | Heather Cornell |
Major Backers & Investors (AXIL)
Notable institutional backers of Axil Brands, Inc. include Private Advisory Group LLC, Diversify Wealth Management, LLC, Soltis Investment Advisors LLC, according to Nexqual as of July 26, 2026 at 09:42 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Private Advisory Group LLC | 5.71% |
| Diversify Wealth Management, LLC | 3.18% |
| Soltis Investment Advisors LLC | 3.07% |
| Wells Fargo & Company | 0.68% |
| Fidelity | 0.52% |
| Cetera Investment Advisers | 0.22% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 2.37% |
| Geode Capital | 0.65% |
| BlackRock | 0.33% |
| State Street | 0.22% |
Source: Nexqual, July 26, 2026 at 09:42 UTC.
From Axil Brands, Inc.'s Latest SEC 10-K Filing (filed 2025-08-21)
Key Strengths & Strategy (as disclosed to the SEC)
- We also rely on trademarks, trade secrets, copyrights and unpatented know-how to protect our proprietary rights.   We recognize the value of our intellectual property and have taken, and will continue to take, appropriate measures to safeguard it against misappropriation.
- In addition, all employees and third-party product development consultants agree not to disclose any private or confidential information relating to our technology, trade secrets or intellectual property.   Table of Contents      At May 31, 2025, we held three active U.S. patents and had one pending U.S. patent application covering various aspects of our technology.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| ATPC | Agape ATP Corporation | USD 2.46 | ▼ 2.77% |
| TWG | Top Wealth Group Holding Limite | USD 2.48 | ▼ 2.82% |
| BTTC | Black Titan Corp | USD 0.89 | ▼ 2.48% |
| AUID | authID Inc. | USD 0.75 | ▼ 8.95% |
| ARTV | Artiva Biotherapeutics, Inc. | USD 10.03 | ▲ 0.1% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 26, 2026 at 09:42 UTC. This page is informational and not investment advice.